Global Nucleic Acid Drug Raw Materials Market Growth 2022-2028
Nucleic Acid Drug Raw Materials utilize nucleic acid, which refer to substances such as DNA and RNA that control genetic information, as drugs. These allow targeting of molecules such as mRNA and miRNA that cannot be targeted with traditional low molecular weight drugs and antibody medicines, and there is a great expectation for these drugs as next generation pharmaceuticals. Active research is being conducted globally as it is expected to lead to the creation of drugs which were previously intractable.
The global market for Nucleic Acid Drug Raw Materials is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Nucleic Acid Drug Raw Materials market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Nucleic Acid Drug Raw Materials market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Nucleic Acid Drug Raw Materials market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Nucleic Acid Drug Raw Materials market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Nucleic Acid Drug Raw Materials players cover Danaher Corporation, Merck, Eurofins Scientific, Thermo Fisher Scientific and Agilent Technologies, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Nucleic Acid Drug Raw Materials market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Nucleic Acid Drug Raw Materials market, with both quantitative and qualitative data, to help readers understand how the Nucleic Acid Drug Raw Materials market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Tons.
Market Segmentation:
The study segments the Nucleic Acid Drug Raw Materials market and forecasts the market size by Type (ASO, siRNA and Other), by Application (Research, Pharmaceutical and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
ASO
siRNA
Other
Segmentation by application
Research
Pharmaceutical
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Danaher Corporation
Merck
Eurofins Scientific
Thermo Fisher Scientific
Agilent Technologies
GE Healthcare
Kaneka Eurogentec
GeneDesign
LGC Biosearch Technologies
Bio-synthesis
Guangzhou RiboBio
STA Pharmaceutical
Hongene Biotech
Chapter Introduction
Chapter 1: Scope of Nucleic Acid Drug Raw Materials, Research Methodology, etc.
Chapter 2: Executive Summary, global Nucleic Acid Drug Raw Materials market size (sales and revenue) and CAGR, Nucleic Acid Drug Raw Materials market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Nucleic Acid Drug Raw Materials sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Nucleic Acid Drug Raw Materials sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Nucleic Acid Drug Raw Materials market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Danaher Corporation, Merck, Eurofins Scientific, Thermo Fisher Scientific, Agilent Technologies, GE Healthcare, Kaneka Eurogentec, GeneDesign and LGC Biosearch Technologies, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nucleic Acid Drug Raw Materials Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Nucleic Acid Drug Raw Materials by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Nucleic Acid Drug Raw Materials by Country/Region, 2017, 2022 & 2028
2.2 Nucleic Acid Drug Raw Materials Segment by Type
2.2.1 ASO
2.2.2 siRNA
2.2.3 Other
2.3 Nucleic Acid Drug Raw Materials Sales by Type
2.3.1 Global Nucleic Acid Drug Raw Materials Sales Market Share by Type (2017-2022)
2.3.2 Global Nucleic Acid Drug Raw Materials Revenue and Market Share by Type (2017-2022)
2.3.3 Global Nucleic Acid Drug Raw Materials Sale Price by Type (2017-2022)
2.4 Nucleic Acid Drug Raw Materials Segment by Application
2.4.1 Research
2.4.2 Pharmaceutical
2.4.3 Other
2.5 Nucleic Acid Drug Raw Materials Sales by Application
2.5.1 Global Nucleic Acid Drug Raw Materials Sale Market Share by Application (2017-2022)
2.5.2 Global Nucleic Acid Drug Raw Materials Revenue and Market Share by Application (2017-2022)
2.5.3 Global Nucleic Acid Drug Raw Materials Sale Price by Application (2017-2022)
3 Global Nucleic Acid Drug Raw Materials by Company
3.1 Global Nucleic Acid Drug Raw Materials Breakdown Data by Company
3.1.1 Global Nucleic Acid Drug Raw Materials Annual Sales by Company (2020-2022)
3.1.2 Global Nucleic Acid Drug Raw Materials Sales Market Share by Company (2020-2022)
3.2 Global Nucleic Acid Drug Raw Materials Annual Revenue by Company (2020-2022)
3.2.1 Global Nucleic Acid Drug Raw Materials Revenue by Company (2020-2022)
3.2.2 Global Nucleic Acid Drug Raw Materials Revenue Market Share by Company (2020-2022)
3.3 Global Nucleic Acid Drug Raw Materials Sale Price by Company
3.4 Key Manufacturers Nucleic Acid Drug Raw Materials Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nucleic Acid Drug Raw Materials Product Location Distribution
3.4.2 Players Nucleic Acid Drug Raw Materials Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Nucleic Acid Drug Raw Materials by Geographic Region
4.1 World Historic Nucleic Acid Drug Raw Materials Market Size by Geographic Region (2017-2022)
4.1.1 Global Nucleic Acid Drug Raw Materials Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Nucleic Acid Drug Raw Materials Annual Revenue by Geographic Region
4.2 World Historic Nucleic Acid Drug Raw Materials Market Size by Country/Region (2017-2022)
4.2.1 Global Nucleic Acid Drug Raw Materials Annual Sales by Country/Region (2017-2022)
4.2.2 Global Nucleic Acid Drug Raw Materials Annual Revenue by Country/Region
4.3 Americas Nucleic Acid Drug Raw Materials Sales Growth
4.4 APAC Nucleic Acid Drug Raw Materials Sales Growth
4.5 Europe Nucleic Acid Drug Raw Materials Sales Growth
4.6 Middle East & Africa Nucleic Acid Drug Raw Materials Sales Growth
5 Americas
5.1 Americas Nucleic Acid Drug Raw Materials Sales by Country
5.1.1 Americas Nucleic Acid Drug Raw Materials Sales by Country (2017-2022)
5.1.2 Americas Nucleic Acid Drug Raw Materials Revenue by Country (2017-2022)
5.2 Americas Nucleic Acid Drug Raw Materials Sales by Type
5.3 Americas Nucleic Acid Drug Raw Materials Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic Acid Drug Raw Materials Sales by Region
6.1.1 APAC Nucleic Acid Drug Raw Materials Sales by Region (2017-2022)
6.1.2 APAC Nucleic Acid Drug Raw Materials Revenue by Region (2017-2022)
6.2 APAC Nucleic Acid Drug Raw Materials Sales by Type
6.3 APAC Nucleic Acid Drug Raw Materials Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Nucleic Acid Drug Raw Materials by Country
7.1.1 Europe Nucleic Acid Drug Raw Materials Sales by Country (2017-2022)
7.1.2 Europe Nucleic Acid Drug Raw Materials Revenue by Country (2017-2022)
7.2 Europe Nucleic Acid Drug Raw Materials Sales by Type
7.3 Europe Nucleic Acid Drug Raw Materials Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nucleic Acid Drug Raw Materials by Country
8.1.1 Middle East & Africa Nucleic Acid Drug Raw Materials Sales by Country (2017-2022)
8.1.2 Middle East & Africa Nucleic Acid Drug Raw Materials Revenue by Country (2017-2022)
8.2 Middle East & Africa Nucleic Acid Drug Raw Materials Sales by Type
8.3 Middle East & Africa Nucleic Acid Drug Raw Materials Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nucleic Acid Drug Raw Materials
10.3 Manufacturing Process Analysis of Nucleic Acid Drug Raw Materials
10.4 Industry Chain Structure of Nucleic Acid Drug Raw Materials
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nucleic Acid Drug Raw Materials Distributors
11.3 Nucleic Acid Drug Raw Materials Customer
12 World Forecast Review for Nucleic Acid Drug Raw Materials by Geographic Region
12.1 Global Nucleic Acid Drug Raw Materials Market Size Forecast by Region
12.1.1 Global Nucleic Acid Drug Raw Materials Forecast by Region (2023-2028)
12.1.2 Global Nucleic Acid Drug Raw Materials Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nucleic Acid Drug Raw Materials Forecast by Type
12.7 Global Nucleic Acid Drug Raw Materials Forecast by Application
13 Key Players Analysis
13.1 Danaher Corporation
13.1.1 Danaher Corporation Company Information
13.1.2 Danaher Corporation Nucleic Acid Drug Raw Materials Product Offered
13.1.3 Danaher Corporation Nucleic Acid Drug Raw Materials Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Danaher Corporation Main Business Overview
13.1.5 Danaher Corporation Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Nucleic Acid Drug Raw Materials Product Offered
13.2.3 Merck Nucleic Acid Drug Raw Materials Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Eurofins Scientific
13.3.1 Eurofins Scientific Company Information
13.3.2 Eurofins Scientific Nucleic Acid Drug Raw Materials Product Offered
13.3.3 Eurofins Scientific Nucleic Acid Drug Raw Materials Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Eurofins Scientific Main Business Overview
13.3.5 Eurofins Scientific Latest Developments
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Information
13.4.2 Thermo Fisher Scientific Nucleic Acid Drug Raw Materials Product Offered
13.4.3 Thermo Fisher Scientific Nucleic Acid Drug Raw Materials Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Thermo Fisher Scientific Main Business Overview
13.4.5 Thermo Fisher Scientific Latest Developments
13.5 Agilent Technologies
13.5.1 Agilent Technologies Company Information
13.5.2 Agilent Technologies Nucleic Acid Drug Raw Materials Product Offered
13.5.3 Agilent Technologies Nucleic Acid Drug Raw Materials Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Agilent Technologies Main Business Overview
13.5.5 Agilent Technologies Latest Developments
13.6 GE Healthcare
13.6.1 GE Healthcare Company Information
13.6.2 GE Healthcare Nucleic Acid Drug Raw Materials Product Offered
13.6.3 GE Healthcare Nucleic Acid Drug Raw Materials Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 GE Healthcare Main Business Overview
13.6.5 GE Healthcare Latest Developments
13.7 Kaneka Eurogentec
13.7.1 Kaneka Eurogentec Company Information
13.7.2 Kaneka Eurogentec Nucleic Acid Drug Raw Materials Product Offered
13.7.3 Kaneka Eurogentec Nucleic Acid Drug Raw Materials Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Kaneka Eurogentec Main Business Overview
13.7.5 Kaneka Eurogentec Latest Developments
13.8 GeneDesign
13.8.1 GeneDesign Company Information
13.8.2 GeneDesign Nucleic Acid Drug Raw Materials Product Offered
13.8.3 GeneDesign Nucleic Acid Drug Raw Materials Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 GeneDesign Main Business Overview
13.8.5 GeneDesign Latest Developments
13.9 LGC Biosearch Technologies
13.9.1 LGC Biosearch Technologies Company Information
13.9.2 LGC Biosearch Technologies Nucleic Acid Drug Raw Materials Product Offered
13.9.3 LGC Biosearch Technologies Nucleic Acid Drug Raw Materials Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 LGC Biosearch Technologies Main Business Overview
13.9.5 LGC Biosearch Technologies Latest Developments
13.10 Bio-synthesis
13.10.1 Bio-synthesis Company Information
13.10.2 Bio-synthesis Nucleic Acid Drug Raw Materials Product Offered
13.10.3 Bio-synthesis Nucleic Acid Drug Raw Materials Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Bio-synthesis Main Business Overview
13.10.5 Bio-synthesis Latest Developments
13.11 Guangzhou RiboBio
13.11.1 Guangzhou RiboBio Company Information
13.11.2 Guangzhou RiboBio Nucleic Acid Drug Raw Materials Product Offered
13.11.3 Guangzhou RiboBio Nucleic Acid Drug Raw Materials Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Guangzhou RiboBio Main Business Overview
13.11.5 Guangzhou RiboBio Latest Developments
13.12 STA Pharmaceutical
13.12.1 STA Pharmaceutical Company Information
13.12.2 STA Pharmaceutical Nucleic Acid Drug Raw Materials Product Offered
13.12.3 STA Pharmaceutical Nucleic Acid Drug Raw Materials Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 STA Pharmaceutical Main Business Overview
13.12.5 STA Pharmaceutical Latest Developments
13.13 Hongene Biotech
13.13.1 Hongene Biotech Company Information
13.13.2 Hongene Biotech Nucleic Acid Drug Raw Materials Product Offered
13.13.3 Hongene Biotech Nucleic Acid Drug Raw Materials Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Hongene Biotech Main Business Overview
13.13.5 Hongene Biotech Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Nucleic Acid Drug Raw Materials Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Nucleic Acid Drug Raw Materials Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of ASO
Table 4. Major Players of siRNA
Table 5. Major Players of Other
Table 6. Global Nucleic Acid Drug Raw Materials Sales by Type (2017-2022) & (Tons)
Table 7. Global Nucleic Acid Drug Raw Materials Sales Market Share by Type (2017-2022)
Table 8. Global Nucleic Acid Drug Raw Materials Revenue by Type (2017-2022) & ($ million)
Table 9. Global Nucleic Acid Drug Raw Materials Revenue Market Share by Type (2017-2022)
Table 10. Global Nucleic Acid Drug Raw Materials Sale Price by Type (2017-2022) & (US$/Ton)
Table 11. Global Nucleic Acid Drug Raw Materials Sales by Application (2017-2022) & (Tons)
Table 12. Global Nucleic Acid Drug Raw Materials Sales Market Share by Application (2017-2022)
Table 13. Global Nucleic Acid Drug Raw Materials Revenue by Application (2017-2022)
Table 14. Global Nucleic Acid Drug Raw Materials Revenue Market Share by Application (2017-2022)
Table 15. Global Nucleic Acid Drug Raw Materials Sale Price by Application (2017-2022) & (US$/Ton)
Table 16. Global Nucleic Acid Drug Raw Materials Sales by Company (2020-2022) & (Tons)
Table 17. Global Nucleic Acid Drug Raw Materials Sales Market Share by Company (2020-2022)
Table 18. Global Nucleic Acid Drug Raw Materials Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Nucleic Acid Drug Raw Materials Revenue Market Share by Company (2020-2022)
Table 20. Global Nucleic Acid Drug Raw Materials Sale Price by Company (2020-2022) & (US$/Ton)
Table 21. Key Manufacturers Nucleic Acid Drug Raw Materials Producing Area Distribution and Sales Area
Table 22. Players Nucleic Acid Drug Raw Materials Products Offered
Table 23. Nucleic Acid Drug Raw Materials Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Nucleic Acid Drug Raw Materials Sales by Geographic Region (2017-2022) & (Tons)
Table 27. Global Nucleic Acid Drug Raw Materials Sales Market Share Geographic Region (2017-2022)
Table 28. Global Nucleic Acid Drug Raw Materials Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Nucleic Acid Drug Raw Materials Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Nucleic Acid Drug Raw Materials Sales by Country/Region (2017-2022) & (Tons)
Table 31. Global Nucleic Acid Drug Raw Materials Sales Market Share by Country/Region (2017-2022)
Table 32. Global Nucleic Acid Drug Raw Materials Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Nucleic Acid Drug Raw Materials Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Nucleic Acid Drug Raw Materials Sales by Country (2017-2022) & (Tons)
Table 35. Americas Nucleic Acid Drug Raw Materials Sales Market Share by Country (2017-2022)
Table 36. Americas Nucleic Acid Drug Raw Materials Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Nucleic Acid Drug Raw Materials Revenue Market Share by Country (2017-2022)
Table 38. Americas Nucleic Acid Drug Raw Materials Sales by Type (2017-2022) & (Tons)
Table 39. Americas Nucleic Acid Drug Raw Materials Sales Market Share by Type (2017-2022)
Table 40. Americas Nucleic Acid Drug Raw Materials Sales by Application (2017-2022) & (Tons)
Table 41. Americas Nucleic Acid Drug Raw Materials Sales Market Share by Application (2017-2022)
Table 42. APAC Nucleic Acid Drug Raw Materials Sales by Region (2017-2022) & (Tons)
Table 43. APAC Nucleic Acid Drug Raw Materials Sales Market Share by Region (2017-2022)
Table 44. APAC Nucleic Acid Drug Raw Materials Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Nucleic Acid Drug Raw Materials Revenue Market Share by Region (2017-2022)
Table 46. APAC Nucleic Acid Drug Raw Materials Sales by Type (2017-2022) & (Tons)
Table 47. APAC Nucleic Acid Drug Raw Materials Sales Market Share by Type (2017-2022)
Table 48. APAC Nucleic Acid Drug Raw Materials Sales by Application (2017-2022) & (Tons)
Table 49. APAC Nucleic Acid Drug Raw Materials Sales Market Share by Application (2017-2022)
Table 50. Europe Nucleic Acid Drug Raw Materials Sales by Country (2017-2022) & (Tons)
Table 51. Europe Nucleic Acid Drug Raw Materials Sales Market Share by Country (2017-2022)
Table 52. Europe Nucleic Acid Drug Raw Materials Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Nucleic Acid Drug Raw Materials Revenue Market Share by Country (2017-2022)
Table 54. Europe Nucleic Acid Drug Raw Materials Sales by Type (2017-2022) & (Tons)
Table 55. Europe Nucleic Acid Drug Raw Materials Sales Market Share by Type (2017-2022)
Table 56. Europe Nucleic Acid Drug Raw Materials Sales by Application (2017-2022) & (Tons)
Table 57. Europe Nucleic Acid Drug Raw Materials Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Nucleic Acid Drug Raw Materials Sales by Country (2017-2022) & (Tons)
Table 59. Middle East & Africa Nucleic Acid Drug Raw Materials Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Nucleic Acid Drug Raw Materials Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Nucleic Acid Drug Raw Materials Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Nucleic Acid Drug Raw Materials Sales by Type (2017-2022) & (Tons)
Table 63. Middle East & Africa Nucleic Acid Drug Raw Materials Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Nucleic Acid Drug Raw Materials Sales by Application (2017-2022) & (Tons)
Table 65. Middle East & Africa Nucleic Acid Drug Raw Materials Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Nucleic Acid Drug Raw Materials
Table 67. Key Market Challenges & Risks of Nucleic Acid Drug Raw Materials
Table 68. Key Industry Trends of Nucleic Acid Drug Raw Materials
Table 69. Nucleic Acid Drug Raw Materials Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Nucleic Acid Drug Raw Materials Distributors List
Table 72. Nucleic Acid Drug Raw Materials Customer List
Table 73. Global Nucleic Acid Drug Raw Materials Sales Forecast by Region (2023-2028) & (Tons)
Table 74. Global Nucleic Acid Drug Raw Materials Sales Market Forecast by Region
Table 75. Global Nucleic Acid Drug Raw Materials Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Nucleic Acid Drug Raw Materials Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Nucleic Acid Drug Raw Materials Sales Forecast by Country (2023-2028) & (Tons)
Table 78. Americas Nucleic Acid Drug Raw Materials Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Nucleic Acid Drug Raw Materials Sales Forecast by Region (2023-2028) & (Tons)
Table 80. APAC Nucleic Acid Drug Raw Materials Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Nucleic Acid Drug Raw Materials Sales Forecast by Country (2023-2028) & (Tons)
Table 82. Europe Nucleic Acid Drug Raw Materials Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Nucleic Acid Drug Raw Materials Sales Forecast by Country (2023-2028) & (Tons)
Table 84. Middle East & Africa Nucleic Acid Drug Raw Materials Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Nucleic Acid Drug Raw Materials Sales Forecast by Type (2023-2028) & (Tons)
Table 86. Global Nucleic Acid Drug Raw Materials Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Nucleic Acid Drug Raw Materials Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Nucleic Acid Drug Raw Materials Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Nucleic Acid Drug Raw Materials Sales Forecast by Application (2023-2028) & (Tons)
Table 90. Global Nucleic Acid Drug Raw Materials Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Nucleic Acid Drug Raw Materials Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Nucleic Acid Drug Raw Materials Revenue Market Share Forecast by Application (2023-2028)
Table 93. Danaher Corporation Basic Information, Nucleic Acid Drug Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 94. Danaher Corporation Nucleic Acid Drug Raw Materials Product Offered
Table 95. Danaher Corporation Nucleic Acid Drug Raw Materials Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 96. Danaher Corporation Main Business
Table 97. Danaher Corporation Latest Developments
Table 98. Merck Basic Information, Nucleic Acid Drug Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 99. Merck Nucleic Acid Drug Raw Materials Product Offered
Table 100. Merck Nucleic Acid Drug Raw Materials Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 101. Merck Main Business
Table 102. Merck Latest Developments
Table 103. Eurofins Scientific Basic Information, Nucleic Acid Drug Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 104. Eurofins Scientific Nucleic Acid Drug Raw Materials Product Offered
Table 105. Eurofins Scientific Nucleic Acid Drug Raw Materials Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 106. Eurofins Scientific Main Business
Table 107. Eurofins Scientific Latest Developments
Table 108. Thermo Fisher Scientific Basic Information, Nucleic Acid Drug Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 109. Thermo Fisher Scientific Nucleic Acid Drug Raw Materials Product Offered
Table 110. Thermo Fisher Scientific Nucleic Acid Drug Raw Materials Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 111. Thermo Fisher Scientific Main Business
Table 112. Thermo Fisher Scientific Latest Developments
Table 113. Agilent Technologies Basic Information, Nucleic Acid Drug Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 114. Agilent Technologies Nucleic Acid Drug Raw Materials Product Offered
Table 115. Agilent Technologies Nucleic Acid Drug Raw Materials Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 116. Agilent Technologies Main Business
Table 117. Agilent Technologies Latest Developments
Table 118. GE Healthcare Basic Information, Nucleic Acid Drug Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 119. GE Healthcare Nucleic Acid Drug Raw Materials Product Offered
Table 120. GE Healthcare Nucleic Acid Drug Raw Materials Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 121. GE Healthcare Main Business
Table 122. GE Healthcare Latest Developments
Table 123. Kaneka Eurogentec Basic Information, Nucleic Acid Drug Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 124. Kaneka Eurogentec Nucleic Acid Drug Raw Materials Product Offered
Table 125. Kaneka Eurogentec Nucleic Acid Drug Raw Materials Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 126. Kaneka Eurogentec Main Business
Table 127. Kaneka Eurogentec Latest Developments
Table 128. GeneDesign Basic Information, Nucleic Acid Drug Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 129. GeneDesign Nucleic Acid Drug Raw Materials Product Offered
Table 130. GeneDesign Nucleic Acid Drug Raw Materials Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 131. GeneDesign Main Business
Table 132. GeneDesign Latest Developments
Table 133. LGC Biosearch Technologies Basic Information, Nucleic Acid Drug Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 134. LGC Biosearch Technologies Nucleic Acid Drug Raw Materials Product Offered
Table 135. LGC Biosearch Technologies Nucleic Acid Drug Raw Materials Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 136. LGC Biosearch Technologies Main Business
Table 137. LGC Biosearch Technologies Latest Developments
Table 138. Bio-synthesis Basic Information, Nucleic Acid Drug Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 139. Bio-synthesis Nucleic Acid Drug Raw Materials Product Offered
Table 140. Bio-synthesis Nucleic Acid Drug Raw Materials Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 141. Bio-synthesis Main Business
Table 142. Bio-synthesis Latest Developments
Table 143. Guangzhou RiboBio Basic Information, Nucleic Acid Drug Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 144. Guangzhou RiboBio Nucleic Acid Drug Raw Materials Product Offered
Table 145. Guangzhou RiboBio Nucleic Acid Drug Raw Materials Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 146. Guangzhou RiboBio Main Business
Table 147. Guangzhou RiboBio Latest Developments
Table 148. STA Pharmaceutical Basic Information, Nucleic Acid Drug Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 149. STA Pharmaceutical Nucleic Acid Drug Raw Materials Product Offered
Table 150. STA Pharmaceutical Nucleic Acid Drug Raw Materials Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 151. STA Pharmaceutical Main Business
Table 152. STA Pharmaceutical Latest Developments
Table 153. Hongene Biotech Basic Information, Nucleic Acid Drug Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 154. Hongene Biotech Nucleic Acid Drug Raw Materials Product Offered
Table 155. Hongene Biotech Nucleic Acid Drug Raw Materials Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 156. Hongene Biotech Main Business
Table 157. Hongene Biotech Latest Developments
List of Figures
Figure 1. Picture of Nucleic Acid Drug Raw Materials
Figure 2. Nucleic Acid Drug Raw Materials Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nucleic Acid Drug Raw Materials Sales Growth Rate 2017-2028 (Tons)
Figure 7. Global Nucleic Acid Drug Raw Materials Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Nucleic Acid Drug Raw Materials Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of ASO
Figure 10. Product Picture of siRNA
Figure 11. Product Picture of Other
Figure 12. Global Nucleic Acid Drug Raw Materials Sales Market Share by Type in 2021
Figure 13. Global Nucleic Acid Drug Raw Materials Revenue Market Share by Type (2017-2022)
Figure 14. Nucleic Acid Drug Raw Materials Consumed in Research
Figure 15. Global Nucleic Acid Drug Raw Materials Market: Research (2017-2022) & (Tons)
Figure 16. Nucleic Acid Drug Raw Materials Consumed in Pharmaceutical
Figure 17. Global Nucleic Acid Drug Raw Materials Market: Pharmaceutical (2017-2022) & (Tons)
Figure 18. Nucleic Acid Drug Raw Materials Consumed in Other
Figure 19. Global Nucleic Acid Drug Raw Materials Market: Other (2017-2022) & (Tons)
Figure 20. Global Nucleic Acid Drug Raw Materials Sales Market Share by Application (2017-2022)
Figure 21. Global Nucleic Acid Drug Raw Materials Revenue Market Share by Application in 2021
Figure 22. Nucleic Acid Drug Raw Materials Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Nucleic Acid Drug Raw Materials Revenue Market Share by Company in 2021
Figure 24. Global Nucleic Acid Drug Raw Materials Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Nucleic Acid Drug Raw Materials Revenue Market Share by Geographic Region in 2021
Figure 26. Global Nucleic Acid Drug Raw Materials Sales Market Share by Region (2017-2022)
Figure 27. Global Nucleic Acid Drug Raw Materials Revenue Market Share by Country/Region in 2021
Figure 28. Americas Nucleic Acid Drug Raw Materials Sales 2017-2022 (Tons)
Figure 29. Americas Nucleic Acid Drug Raw Materials Revenue 2017-2022 ($ Millions)
Figure 30. APAC Nucleic Acid Drug Raw Materials Sales 2017-2022 (Tons)
Figure 31. APAC Nucleic Acid Drug Raw Materials Revenue 2017-2022 ($ Millions)
Figure 32. Europe Nucleic Acid Drug Raw Materials Sales 2017-2022 (Tons)
Figure 33. Europe Nucleic Acid Drug Raw Materials Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Nucleic Acid Drug Raw Materials Sales 2017-2022 (Tons)
Figure 35. Middle East & Africa Nucleic Acid Drug Raw Materials Revenue 2017-2022 ($ Millions)
Figure 36. Americas Nucleic Acid Drug Raw Materials Sales Market Share by Country in 2021
Figure 37. Americas Nucleic Acid Drug Raw Materials Revenue Market Share by Country in 2021
Figure 38. United States Nucleic Acid Drug Raw Materials Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Nucleic Acid Drug Raw Materials Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Nucleic Acid Drug Raw Materials Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Nucleic Acid Drug Raw Materials Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Nucleic Acid Drug Raw Materials Sales Market Share by Region in 2021
Figure 43. APAC Nucleic Acid Drug Raw Materials Revenue Market Share by Regions in 2021
Figure 44. China Nucleic Acid Drug Raw Materials Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Nucleic Acid Drug Raw Materials Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Nucleic Acid Drug Raw Materials Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Nucleic Acid Drug Raw Materials Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Nucleic Acid Drug Raw Materials Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Nucleic Acid Drug Raw Materials Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Nucleic Acid Drug Raw Materials Sales Market Share by Country in 2021
Figure 51. Europe Nucleic Acid Drug Raw Materials Revenue Market Share by Country in 2021
Figure 52. Germany Nucleic Acid Drug Raw Materials Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Nucleic Acid Drug Raw Materials Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Nucleic Acid Drug Raw Materials Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Nucleic Acid Drug Raw Materials Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Nucleic Acid Drug Raw Materials Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Nucleic Acid Drug Raw Materials Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Nucleic Acid Drug Raw Materials Revenue Market Share by Country in 2021
Figure 59. Egypt Nucleic Acid Drug Raw Materials Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Nucleic Acid Drug Raw Materials Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Nucleic Acid Drug Raw Materials Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Nucleic Acid Drug Raw Materials Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Nucleic Acid Drug Raw Materials Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Nucleic Acid Drug Raw Materials in 2021
Figure 65. Manufacturing Process Analysis of Nucleic Acid Drug Raw Materials
Figure 66. Industry Chain Structure of Nucleic Acid Drug Raw Materials
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Reason to Buy
- Current and future of Chemical & Material Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Chemical & Material Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Chemical & Material Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Chemical & Material Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets